Evelyn Zeindl‐Eberhart

Author

Ludwig-Maximilians-Universität München

Also Known As

E Zeindl-Eberhart, E. Zeindl-Eberhart, Evelyn Zeindl-Eberhart, Evelyn Zeindl‐Eberhart

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München Wita Proteomics (Germany)Max Planck Institute for Infection Biology Max Planck Society Heidelberg University

About

Evelyn Zeindl‐Eberhart is an author at Ludwig-Maximilians-Universität München specializing in medicine, cancer research, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	665
2	Cell Biology	3	3	64
3	Biochemistry	2	2	201
4	Health Sciences	1	1	100
5	Natural Sciences	1	1	101

Evelyn Zeindl‐Eberhart

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer Jens Neumann, Evelyn Zeindl‐Eberhart, Thomas Kirchner, Pathology - Research and Practice Kras MutationsOncologySomatic VariantMedicinePathology	2009	354
Generalized crystal-storing histiocytosis associated with monoclonal gammopathy: molecular analysis of a disorder with rapid clinical course and review of the literature Annette Lebeau, Evelyn Zeindl‐Eberhart, Eva‐Christina Müller, Blood	2002	168
Protein composition of the human heart: The construction of a myocardial two‐dimensional electrophoresis database Peter R. Jungblut, Albrecht Otto, Evelyn Zeindl‐Eberhart, Electrophoresis Cardiac MuscleProtein CompositionStructural BioinformaticsMolecular BiologyHuman Heart	1994	101
Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas Evelyn Zeindl‐Eberhart, Sibylle Haraida, Sibylle Liebmann, Hepatology Aldo-keto ReductasePathologyTumor BiologyTumor-associated Protein VariantsProteomics	2004	100
Identification of tumor-associated protein variants during rat hepatocarcinogenesis. Aldose reductase. Evelyn Zeindl‐Eberhart, Peter R. Jungblut, Albrecht Otto, Journal of Biological Chemistry	1994	62
Chromogenic <i>in situ</i> hybridization for Her‐2/neu‐oncogene in breast cancer: comparison of a new dual‐colour chromogenic <i>in situ</i> hybridization with immunohistochemistry and fluorescence <i>in situ</i> hybridization Doris Mayr, Sibylle Heim, Kerstin Weyrauch, Histopathology	2009	54
β-Catenin mutations in 2 nested stromal epithelial tumors of the liver—a neoplasia with defective mesenchymal-epithelial transition Gerald Assmann, Roland Kappler, Evelyn Zeindl‐Eberhart, Human Pathology Tumor BiologyLiver—a NeoplasiaTumoral PathologyTissue DevelopmentHepatobiliary Tumor	2012	46
The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines. Vivian Arrias Herrera, Evelyn Zeindl‐Eberhart, Andreas Jung, PubMed	2011	43
Proteome analysis of rat hepatomas: Carcinogen-dependent tumor-associated protein variants Evelyn Zeindl‐Eberhart, Sabine Klugbauer, Nicola Dimitrijevic, Electrophoresis	2001	36
Variant protein patterns in hepatomas and transformed liver cell lines as determined by high resolution two-dimensional gel electrophoresis (2DE) Evelyn Zeindl‐Eberhart, H. Rabes Carcinogenesis	1992	32

Page 1